FDMT vs HON · rev $37.0K vs P/E 36, rev $9.72B
4D Molecular Therapeutics Inc (FDMT) versus Honeywell International Inc (HON) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
FDMT currently screens at market cap $518.1M. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Not investment advice. Open the FDMT and HON stock pages for the full models.
Not investment advice.